Healthcare provider profile · identity verified

Jeremy Jacob John, M.D.

Family Practice · LITTLETON, CO · NPI 1831535962

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	633	235
Levothyroxine Sodium	Levothyroxine Sodium	478	168
Lisinopril	Lisinopril	476	163
Amlodipine Besylate	Amlodipine Besylate	283	102
Rosuvastatin Calcium	Rosuvastatin Calcium	272	107
Tamsulosin Hcl	Tamsulosin Hcl	224	85
Simvastatin	Simvastatin	219	85
Losartan Potassium	Losartan Potassium	215	80
Omeprazole	Omeprazole	194	71
Metformin Hcl	Metformin Hcl	181	64
Eliquis	Apixaban	168	49
Gabapentin	Gabapentin	160	58
Metoprolol Succinate	Metoprolol Succinate	160	60
Allopurinol	Allopurinol	143	53
Pantoprazole Sodium	Pantoprazole Sodium	141	55
Trazodone Hcl	Trazodone Hcl	136	55
Metoprolol Tartrate	Metoprolol Tartrate	107	34
Metformin Hcl Er	Metformin Hcl	106	39
Albuterol Sulfate Hfa	Albuterol Sulfate	105	56
Hydrochlorothiazide	Hydrochlorothiazide	99	37
Zolpidem Tartrate	Zolpidem Tartrate	96	26
Tramadol Hcl	Tramadol Hcl	92	22
Escitalopram Oxalate	Escitalopram Oxalate	82	32
Potassium Chloride	Potassium Chloride	78	35
Prednisone	Prednisone	78	58
Finasteride	Finasteride	76	29
Furosemide	Furosemide	74	30
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	72	30
Duloxetine Hcl	Duloxetine Hcl	70	25
Alprazolam	Alprazolam	69	20
Sertraline Hcl	Sertraline Hcl	63	25
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	61	13
Spironolactone	Spironolactone	56	21
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	50	41
Synthroid	Levothyroxine Sodium	49	19
Atenolol	Atenolol	47	18
Tizanidine Hcl	Tizanidine Hcl	47	13
Famotidine	Famotidine	46	20
Mounjaro	Tirzepatide	46	suppressed
Carvedilol	Carvedilol	45	17
Alendronate Sodium	Alendronate Sodium	44	16
Pioglitazone Hcl	Pioglitazone Hcl	44	14
Xarelto	Rivaroxaban	44	14
Methocarbamol	Methocarbamol	43	30
Symbicort	Budesonide/Formoterol Fumarate	43	16
Fluoxetine Hcl	Fluoxetine Hcl	42	15
Meloxicam	Meloxicam	42	15
Donepezil Hcl	Donepezil Hcl	39	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	39	18
Pravastatin Sodium	Pravastatin Sodium	39	15
Bupropion Hcl Sr	Bupropion Hcl	38	12
Citalopram Hbr	Citalopram Hydrobromide	38	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	38	13
Lorazepam	Lorazepam	37	suppressed
Ezetimibe	Ezetimibe	36	13
Glimepiride	Glimepiride	36	11
Buspirone Hcl	Buspirone Hcl	35	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	34	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	34	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	20
Testosterone Cypionate	Testosterone Cypionate	32	11
Clopidogrel	Clopidogrel Bisulfate	31	suppressed
Fluticasone Propionate	Fluticasone Propionate	30	13
Acyclovir	Acyclovir	29	14
Jardiance	Empagliflozin	29	suppressed
Lovastatin	Lovastatin	29	suppressed
Montelukast Sodium	Montelukast Sodium	29	12
Oxycodone Hcl	Oxycodone Hcl	29	suppressed
Propranolol Hcl	Propranolol Hcl	28	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Celecoxib	Celecoxib	25	suppressed
Glipizide	Glipizide	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Myrbetriq	Mirabegron	25	suppressed
Benazepril Hcl	Benazepril Hcl	24	suppressed
Fenofibrate	Fenofibrate	24	suppressed
Pregabalin	Pregabalin	24	11
Diazepam	Diazepam	23	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Lamotrigine	Lamotrigine	23	suppressed
Naproxen	Naproxen	23	16
Farxiga	Dapagliflozin Propanediol	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	suppressed
Bupropion Xl	Bupropion Hcl	21	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	13
Doxycycline Hyclate	Doxycycline Hyclate	20	19
Nebivolol Hcl	Nebivolol Hcl	20	suppressed
Trulicity	Dulaglutide	20	suppressed
Baclofen	Baclofen	19	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Temazepam	Temazepam	19	suppressed
Methylprednisolone	Methylprednisolone	17	15
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Ozempic	Semaglutide	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Promethazine Hcl	Promethazine Hcl	16	suppressed
Clonazepam	Clonazepam	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	15
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Colchicine	Colchicine	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Torsemide	Torsemide	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Valsartan	Valsartan	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Azithromycin	Azithromycin	11	11
Dextroamphetamine Sulfate	Dextroamphetamine Sulfate	11	suppressed
Lactulose	Lactulose	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Ramipril	Ramipril	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error